Serum factors inhibit melanoma cell surface expression of type I and type II IGF receptors

J Recept Signal Transduct Res. 1996 Jan-Mar;16(1-2):115-34. doi: 10.3109/10799899609039944.

Abstract

We have identified one class of IGF-I-binding sites and two classes of IGF-II-binding sites at the surface of the melanoma cell line IGR39. By means of affinity labeling with 125I-IGF-I, 290-300 kDa form was characterized. Using 125I-IGF-II, a 270 kDa polypeptide was labeled, corresponding to the type II IGF receptor. In the two serials of experiments, the order of potency in inhibiting 125I-IGF-I or 125I-IGF-II labeling of IGF-related peptides and alpha IR3, an antibody directed against type I receptor alpha subunit, was the same as in competition experiments. When IGR39 cells were cultured in a serum-free medium, the number of both high affinity IGF-II and IGF-I binding sites was increased, by 8- and 5-fold respectively, without any significant change in Kd values. In both culture conditions, we found IGFBP-2, -3 -4 and a 30 kDa form which Mr was consistent with IGFBP-5 or -6. Except for IGFBP-2, the amount of secreted IGFBPs was modified depending on culture conditions: in conditioned medium from cells cultured with 10% FCS, the amount of IGFBP-3 or -4 was higher, and the amount of the 30 kDa IGFBP was lower when compared to conditioned medium from cells cultured in serum-free medium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Affinity Labels / metabolism
  • Binding Sites
  • Binding, Competitive
  • Blood Proteins / pharmacology*
  • Blotting, Western
  • Cell Line
  • Culture Media, Serum-Free
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Melanoma / metabolism*
  • Receptor, IGF Type 1 / biosynthesis*
  • Receptor, IGF Type 2 / biosynthesis*

Substances

  • Affinity Labels
  • Blood Proteins
  • Culture Media, Serum-Free
  • Receptor, IGF Type 2
  • Receptor, IGF Type 1